LeJeune Puetz Investment Counsel LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
LeJeune Puetz Investment Counsel LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q1 2023$610,420
+1.4%
6,6350.0%0.22%
-2.7%
Q4 2022$601,927
+19.4%
6,6350.0%0.22%
+8.2%
Q3 2022$504,000
-3.1%
6,635
+7.7%
0.21%
+3.0%
Q2 2022$520,000
-3.7%
6,1600.0%0.20%
+7.4%
Q1 2022$540,000
+3.6%
6,160
+3.4%
0.19%
+6.8%
Q4 2021$521,000
+7.0%
5,9600.0%0.18%
-0.6%
Q3 2021$487,000
-10.5%
5,9600.0%0.18%
-11.9%
Q2 2021$544,000
+6.9%
5,9600.0%0.20%
+0.5%
Q1 2021$509,000
-9.6%
5,9600.0%0.20%
-17.7%
Q4 2020$563,000
+8.7%
5,9600.0%0.24%
-4.3%
Q3 2020$518,000
-0.6%
5,9600.0%0.25%
-7.0%
Q2 2020$521,000
+6.1%
5,9600.0%0.27%
-4.9%
Q1 2020$491,000
-17.6%
5,960
-5.3%
0.29%
+2.9%
Q4 2019$596,000
+9.0%
6,2910.0%0.28%
+0.4%
Q3 2019$547,000
-4.7%
6,2910.0%0.28%
-6.4%
Q2 2019$574,000
-4.5%
6,291
+0.6%
0.30%
-8.9%
Q1 2019$601,000
+11.9%
6,2560.0%0.33%
-2.7%
Q4 2018$537,000
+5.3%
6,256
+5.6%
0.34%
+13.9%
Q3 2018$510,000
+26.9%
5,925
+11.3%
0.29%
+18.5%
Q2 2018$402,000
-26.6%
5,325
-21.4%
0.25%
-26.2%
Q1 2018$548,000
-6.2%
6,775
-2.5%
0.34%
-6.1%
Q4 2017$584,000
-4.3%
6,950
-2.1%
0.36%
-8.7%
Q3 2017$610,000
+2.9%
7,1000.0%0.39%
-2.5%
Q2 2017$593,000
+12.5%
7,1000.0%0.40%
+6.1%
Q1 2017$527,000
+1.9%
7,1000.0%0.38%
-4.5%
Q4 2016$517,0007,1000.40%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders